JY
SLXP

Jeff Yass’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Jeff Yass’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-41,580
Closed -$7.19M – 10864
2015
Q1 		$7.19M Sell
41,580
-346,713
-89% -$50.9M ﹤0.01% 2246
2014
Q4 		$44.6M Buy
388,293
+19,280
+5% +$2.34M 0.02% 788
2014
Q3 		$57.7M Buy
369,013
+311,079
+537% +$45.1M 0.02% 683
2014
Q2 		$7.15M Buy
57,934
+25,160
+77% +$2.78M ﹤0.01% 2550
2014
Q1 		$3.4M Buy
32,774
+15,809
+93% +$1.62M ﹤0.01% 3448
2013
Q4 		$1.53M Sell
16,965
-160,393
-90% -$12.8M ﹤0.01% 4738
2013
Q3 		$11.9M Buy
177,358
+171,246
+2,802% +$11.8M 0.01% 1720
2013
Q2 		$404K Buy
+6,112
New +$350K ﹤0.01% 6361

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Jeff Yass's SLXP Position: Q2 2015 in Review

Jeff Yass sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 41,580 shares — an estimated $7.19M sold.

Jeff Yass first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $57.7M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Jeff Yass reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Jeff Yass sold 41,580 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $7.19M.
  • Jeff Yass first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Jeff Yass's SALIX PHARMACEUTICALS LTD DEL position peaked at $57.7M in Q3 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.